OmniAb, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from OmniAb, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both fell in each of the last 3 years. Less steady than 96% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $31 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 93% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-18.1×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 57% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 0/3Sales and profit both fell in each of the last 3 years.
Less steady than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 68%
Sales fell 68% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-68% / -29%In 3 years sales changed by -68% while total assets changed by -29%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-9.4×Operating cash was negative last year, while some debt falls due within a year.
Higher than 55% of Healthcare companies in United States.
Cash Cushion Ratio
+5%Cash, after subtracting all debt, equals 5% of its market value (net cash).
Lower than 58% of Healthcare companies in United States.
Tangible Assets Ratio
31%Of every $100 the company owns, $31 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 93% of Healthcare companies in United States.
Tangible Net Worth Ratio
22%Of every $100 of net worth, $22 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 65% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
OmniAb, Inc. made a loss over the last year. OmniAb, Inc. owes $0.10 for every $1 it owns. OmniAb, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossOmniAb, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
2.67The share price is 2.67 times OmniAb, Inc.'s book value per share, higher than 52% of Healthcare companies in United States.
Market cap
$695 MThe total market value of all of OmniAb, Inc.'s shares at today's price (share price × number of shares), larger than 60% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$260 MWhat OmniAb, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.79Net worth divided by the number of shares. The share price of $4.78 is 2.7 times this, which is the P/B above.
Return on equity (ROE)
-16.9%OmniAb, Inc. lost 16.9% of its shareholders' money over the last year, higher than 67% of Healthcare companies in United States.
Owes vs Owns
0.10×OmniAb, Inc. owes $0.10 for every $1 it owns (low), lower than 86% of Healthcare companies in United States.
Dividend yield
NoneOmniAb, Inc. does not currently pay a dividend.
Revenue growth
-29%Revenue fell 29% in the year to Dec 2025, and shrank 32% a year on average over 3 years.
Profit growth
LossOmniAb, Inc. made a loss in each of the last two years.
Profit margin
-347.0%OmniAb, Inc. lost $347 for every $100 of revenue.
Cash vs debt
Net cashOmniAb, Inc. held $34 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For OmniAb, Inc.: $695 M ÷ $260 M (30 Jun 2026) = 2.7.
What is OmniAb, Inc.'s return on equity?
OmniAb, Inc. lost 16.9% of its shareholders' money over the last year, higher than 67% of Healthcare companies in United States.
How much does OmniAb, Inc. owe compared with what it owns?
OmniAb, Inc. owes $0.10 for every $1 it owns (low), lower than 86% of Healthcare companies in United States.
Does OmniAb, Inc. pay a dividend?
No. OmniAb, Inc. does not currently pay a dividend.
Is OmniAb, Inc.'s revenue growing?
Revenue fell 29% in the year to Dec 2025, and shrank 32% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.